This study aims to evaluate the efficacy of hypertonic saline versus crystalloids
(normal Saline/lactated Ringers) in improving clinical outcome in patients with traumatic
brain injury (TBI). Electronic databases and grey literature (unpublished articles)
were searched under different MeSH terms from 1990 to present. Randomized control
trials, case–control studies and prospective cohort studies on decompressive craniectomy
in TBI (>18-year-old). Clinical outcome measures included Glasgow Coma Outcome Scale
(GCOS), Extended GCOS, and mortality. Data were extracted to Review Manager Software.
A total of 115 articles that met the inclusion criteria were retrieved and analyzed.
Ultimately, five studies were included in our meta-analysis, which revealed that patients
with TBI who had hypertonic saline had no statistically significant likelihood of
having a good outcome at discharge or 6 months than those who had crystalloid (odds
ratio [OR]: 0.01; 95% confidence interval (CI): 0.03–0.05; P = 0.65). The relative
risk (RR) of mortality in hypertonic saline versus the crystalloid at discharge or
6-month is RR: 0.80; 95% CI: 0.64–0.99; P = 0.04. The subgroup analysis showed that
the group who had hypertonic solution significantly decreases the number of interventions
versus the crystalloid group OR: 0.53; 95% CI: 0.48–0.59; P < 0.00001 and also reduces
the length of intensive care unit stay (OR: 0.46; 95% CI: 0.21–1.01; P = 0.05). Hypertonic
saline decreases the financial burden, but neither impacts the clinical outcome nor
reduces the mortality. However, further clinical trials are required to prove if hypertonic
saline has any role in improving the clinical and neurological status of patients
with TBI versus the normal saline/lactated Ringers.
Key-words:
Clinical outcome - hypertonic saline - traumatic brain injury